alexa MRSA [Methicillin Resistant Staphylococcus aureus] | India | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Read more

Recommended Journals

Relevant Topics

MRSA [Methicillin Resistant Staphylococcus Aureus]

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Pathophysiology: Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for several difficult-to-treat infections in humans. It is also called oxacillin-resistant Staphylococcus aureus. MRSA is especially troublesome in hospitals, prisons, and nursing homes, where patients with open wounds, invasive devices, and weakened immune systems are at greater risk of nosocomial infection than the general public.S. aureus most commonly colonizes under the anterior nares.

  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Statistics: A total of 26310 isolates were included in the study. The overall prevalence of methicillin resistance during the study period was 41%. Isolation rates for MRSA from outpatients, ward inpatients and ICU were 28, 42 and 43% respectively in 2008 and 27, 49 and 47% respectively in 2009.

  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Treatment: Minor skin and soft tissue infections, such as smaller boils or abscesses, may only require a treatment called incision and drainage.Incision and drainage involves piercing the tip of the boil or abscess with a sterile needle or scalpel to drain the pus and allow the affected area to heal. Before the procedure, you're likely to be given a local anaesthetic to numb the affected area.

  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Major Research: Some semi-toxic fungi/mushrooms excrete broad spectrum antibiotics, not all of which have been fully identified; some have been shown to inhibit the growth of Staphylococcus aureus. An entirely different approach is phage therapy (e.g., at the Eliava Institute in Georgia). Experimental phage therapy tested in mice had a reported efficacy against up to 95% of tested Staphylococcus isolates.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings

adwords